Trial intelligence / Profile preview

Acute Cardiovascular Effects of Nicotine in E-cigarettes (ACE)

NCT03010995Phase 1Withdrawn

Sponsor
University of Louisville
Start
Mar 2018
Primary completion
Jul 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, double-blind trial of nicotine, sponsored by University of Louisville. Primary endpoint: Endothelial function. Planned start Mar 2018; status: withdrawn.

02

Drugs

nicotine

Beyond the preview

Go deeper on NCT03010995.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03010995.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call